|
|
|
|
Bioequivalence of a darunavir/cobicistat
fixed-dose combination tablet versus single agents in healthy volunteers
|
|
|
Reported by Jules Levin
14th Clinical Pharmacology Workshop in HIV April 22-24 2013 Amsterdam
Thomas N Kakuda,1 Tom Van De Casteele,2 Romana Petrovic,2 Magda Opsomer,2 Frank Tomaka,1 Richard MW Hoetelmans2
1Janssen Research & Development LLC, Titusville, NJ, USA; 2Janssen Infectious Diseases BVBA, Beerse, Belgium
|
|
|
|
|
|
|